TikoMed's ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to t

VIKEN, Sweden, Aug. 31, 2022 /PRNewswire/ -- TikoMed, a biopharmaceutical company focused on harnessing the...

Related Keywords

Sweden ,Anders Kristensson ,Ann Logan ,Prnewswire Tikomed ,University Of Warwick ,Scientific Director ,Axolotl Consulting ,Regenerative Medicine ,Amyotrophic Lateral Sclerosis ,Traumatic Brain Injury ,